August 13, 2025
On July 23, the White House released America’s AI Action Plan [PDF]—a national strategy aimed at accelerating artificial intelligence (AI) adoption across key sectors, including health care, where many audiologists and speech-language pathologists (SLPs) work.
The plan contains 90 policy recommendations and follows the January 23 executive order Removing Barriers to American Leadership in Artificial Intelligence. It takes a deregulatory approach to reduce “bureaucratic red tape” and eliminate “onerous” regulations. The plan emphasizes that federal AI funding should not go to states with overly burdensome regulations that could hinder innovation. However, it also affirms that states should retain the right to pass reasonable laws that do not unduly restrict innovation.
Health care is described as “especially slow to adopt” AI because of complex regulations, mistrust of automation, and unclear governance. To accelerate AI adoption, the plan calls for:
The plan emphasizes the need for a workforce that can support AI advancements. Strategies that could impact audiologists and SLPs include:
The plan supports innovation through data-enabled tools and infrastructure improvements. However, details regarding health care data sharing and privacy are still unclear—particularly around consent, governance, and protections against misuse. Data sharing activities outlined in the plan include:
The plan emphasizes rapid deployment, deregulation, and infrastructure expansion, signaling a major shift in how AI will be integrated into health care. But questions remain around ethical safeguards, patient privacy, and the oversight role of agencies like the FDA and the Department of Health and Human Services.
ASHA expects a changing compliance landscape as federal agencies roll out AI standards, pilot programs, and updated regulations. With speed and innovation prioritized over detailed rulemaking, providers should prepare for shifts in privacy requirements, reimbursement models, device approvals, and documentation standards—especially in telepractice and AI-assisted care.
ASHA will continue monitoring developments to ensure policies support innovation while upholding high-quality, ethical patient care.
For questions, please contact reimbursement@asha.org.